Comparison of Pharmacokinetics and Safety of HS627(2 Specifications) Versus PERJETA With a Single Injection

Clinical trial NCT05323981 · COMPLETED

Trial details

NCT number: NCT05323981
Sponsor: BioRay Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Similarity of Pharmacokinetics and Safety

Start date: 2022-04-11
Primary completion: 2022-10-09
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.